NASDAQ: CRNX

Crinetics Pharmaceuticals is a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, with a scientific specialty in G-protein-coupled receptor (GPCR) pharmacology.

Portfolio